4/15/2016 Table 1, Included drugs and their labeled indications ­ Drug Class Review: Newer Antihistamines ­ NCBI Bookshelf

http://www.ncbi.nlm.nih.gov/books/NBK50554/table/introduction.t1/?report=objectonly 1/1

a

b

c

d

Table 1 Included drugs and their labeled indications

DrugTradename(s) Labeled indications Dosage form/Route

Cetirizine hydrochlorideZyrtec SAR; PAR; Chronic Urticaria Syrup/Oral

Reactine SAR ; PAR; Chronic Urticaria Tablet; Chewable tablet; Syrup/Oral

Loratadine Claritin SAR; PAR ; Chronic Urticaria Tablet; ODT ; Syrup; Capsule /Oral

Fexofenadinehydrochloride

Allegra SAR; PAR ; Chronic Urticaria Tablet; ODT; Suspension;Capsule /Oral

DesloratadineClarinex SAR; PAR; Chronic Urticaria Tablet; ODT; Syrup/Oral

Aerius Allergic Rhinitis ; SAR ; ChronicUrticaria

Tablet; Syrup/Oral

Levocetirizine Xyzal SAR; PAR; Chronic Urticaria Tablet; Solution/Oral

AzelastineAstelin SAR Spray; Metered/Nasal

Astepro SAR; PAR Spray; Metered/Nasal

Olopatadine Patanase SAR Spray; Metered/Nasal

Abbreviations: ODT, orally disintegrating tablet; PAR, perennial allergic rhinitis; SAR, seasonal allergic rhinitis.

Only available in Canada.

For children only.

For adults only.

Not available in Canada.

From: Introduction

Drug Class Review: Newer Antihistamines: Final Report Update 2 [Internet].Carson S, Lee N, Thakurta S.Portland (OR): Oregon Health & Science University; 2010 May.

Copyright © 2010 by Oregon Health & Science University, Portland, Oregon 97239. All rights reserved.

NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.

®

®a b c

® a a d

® aa

®d

®ac b

®d

®d

®d

®d